<DOC>
	<DOCNO>NCT01633749</DOCNO>
	<brief_summary>Annual study investigate influenza vaccine ( flu vaccine ) develop 2012/2013 season prevention influenza infection . The immunize effect investigate , well tolerability safety .</brief_summary>
	<brief_title>Annual Study Investigate Inactivated Subunit Influenza Vaccine Due New Virus Strains 2012/2013 Season</brief_title>
	<detailed_description>An open , baseline-controlled study two age group : adult elderly . The subject screen within 14 day prior Visit 1 ( Day 1 ) . At Visit 1 ( Day 1 ) subject vaccinate blood sample baseline serum antihemagglutinin antibody titration . Subjects ask record local systemic reaction daily diary home 72 hour vaccination . One week later ( Visit 2 , Day 8 ) subject return study site hand diary assessment safety tolerability ( reactogenicity overall inconvenience ) . Three week vaccination ( Visit 3 , Day 22 ) subject return study site blood sample assess immunogenicity assessment safety tolerability .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion Criteria 1 . Willing able give inform consent able adhere protocol require study procedure . 2 . Men woman age ≥ 18 ≤ 60 year ≥ 61 year age day study vaccination . 3 . Being good health judge medical history , physical examination ( need ) clinical judgment Investigator . Exclusion Criteria 1 . Known allergic egg , chicken protein , gentamicin constituent vaccine . 2 . A serious adverse reaction previous ( influenza ) vaccination . 3 . Presence significant condition may prohibit inclusion determine investigator . 4 . Seasonal pandemic influenza vaccination laboratory confirm seasonal pandemic influenza infection within previous six month study vaccination plan vaccination study period . 5 . Having condition suppresses immune system autoimmune disorder .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Influenza</keyword>
	<keyword>Vaccine</keyword>
	<keyword>CHMP criterion</keyword>
</DOC>